Exelixis Inc Class of Warrant or Right, Outstanding
Exelixis Inc (EXEL) had Class of Warrant or Right, Outstanding of 2.19 million shares as of 2014-03-31, per its 10-Q filed 2014-05-01.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2014-05-01
- 2014-03-31: Class of Warrant or Right, Outstanding 2.19M shares.
- 2013-12-31: Class of Warrant or Right, Outstanding 1.44M shares.
- 2012-12-31: Class of Warrant or Right, Outstanding 1.44M shares.
- 2011-12-31: Class of Warrant or Right, Outstanding 1.44M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2014-03-31 | 2.19M shares 10-Q · filed 2014-05-01 |
| 2013-12-31 | 1.44M shares 10-K · filed 2014-02-20 |
| 2012-12-31 | 1.44M shares 10-K · filed 2013-02-21 |
| 2011-12-31 | 1.44M shares 10-K · filed 2012-02-22 |
| 2006-06-30 | 750.00K shares 10-K · filed 2012-02-22 |
| 2005-06-30 | 750.00K shares 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |